27.00USD+0.04%Mkt Cap: 1.44B USDP/E: —Last update: 2026-06-10
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kal…
Industry Peers
Biotechnology110.59BUSDP/E 25.9
99.24BDKKP/E 19.1
63.08BUSDP/E 14.7
51.59BEURP/E 33.7
48.23BEURP/E 39.7
38.88BUSDP/E 73.0
31.39BUSDP/E 28.7
31.33BSEKP/E 46.4
Indicators:|
Key Statistics
Company
Market Cap1.44B USD
Enterprise Value1.44B USD
Revenue (TTM)114.48M USD
Gross Profit58.47M USD
Net Income (TTM)-183.44M USD
Revenue/Share2.110 USD
Last Price27.00 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees275
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4834971032
Valuation
P/E (Trailing)—
P/E (Forward)22.55
PEG—
EV/EBITDA-10.37
EV/Revenue12.55
P/S12.55
P/B-509.25
EPS (TTM)-3.94
EPS (Forward)1.20
52W Range
9.830100% of range27.00
52W High27.00 USD
52W Low9.830 USD
Profitability
Gross Margin51.07%
Oper. Margin-57.37%
EBITDA Margin-120.94%
Profit Margin-118.74%
ROE6766.65%
ROA-54.70%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-152.91M USD
CapEx (TTM)929.00K USD
FCF Margin—
FCF Yield—
Net Debt-718.02K USD
Net Debt/EBITDA0.01
Balance Sheet
Debt/Equity-55.91
Current Ratio5.17
Quick Ratio4.97
Book Value/Sh-0.0530 USD
Cash/Share5.354 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 22, 2016
Splits
Last Split1:14
Split DateNov 22, 2016
Analyst Consensus
Rating—
Target (Mean)28.60 USD
Target Range27.00 USD – 35.00 USD
# Analysts5
Ownership
Shares Out.53.24M
Float38.18M
Insiders1.72%
Institutions131.71%
Short Interest
Short Ratio2.0d
Short % Float25.31%
Short % Out.22.64%
Shares Short12.05M
Short (prev mo.)19.65M
Technical
SMA 5023.69 (+14.0%)
SMA 20016.70 (+61.6%)
Beta-0.11
S&P 52W Chg22.64%
Avg Vol (30d)5.76M
Avg Vol (10d)2.79M
Technical Indicators
RSI (14)76.3
MACD0.7741
MACD Signal1.0047
MACD Hist.-0.2306
BB Upper27.05 USD
BB Middle26.85 USD
BB Lower26.66 USD
BB Width1.43%
ATR (14)0.2345 USD
Vol Ratio (20d)1.50x